Matt Berriman, founder of RealVC and ‘The Business of Sport’ panellist at this year’s Sohn Hearts & Minds Conference discusses RealVC, his entrepreneurial learnings and the parallels between sports and business – all on the Talking Tech podcast. Listen to the short podcast episode below.
Talking Tech: Matt Berriman, Founder of RealVC
Matt Berriman, founder of RealVC and ‘The Business of Sport’ panellist at 2022 Sohn Hearts & Minds Conference discusses his entrepreneurial learnings and the parallels between sports and business.



Talking-Tech
Talking Tech: Matt Berriman, Founder of RealVC
Matt Berriman, founder of RealVC and ‘The Business of Sport’ panellist at 2022 Sohn Hearts & Minds Conference discusses his entrepreneurial learnings and the parallels between sports and business.Read Transcript
More Insights
Case Study Highlight: The Baker Heart & Diabetes Institute
Working closely with Indigenous communities, The Baker Heart and Diabetes Institute is working to help tackle heart disease and diabetes in remote communities of Central Australia.
A Heart in a Box: The Gift of Life
A “heart in a box”. It sounds like an ad for Valentine’s Day chocolates. But this box contains an actual human heart which is pumping outside its original body, enabling the gift of life from one person to another.

Bringing Equity and Diversity to Genomic Medicine
Professor Daniel MacArthur, Director of the Centre for Population Genomics has big goals to bring equity and diversity into genomic medicine in Australia, something surprisingly inadequate presently.
WEHI: Art of Science Online Exhibition 2022
WEHI has officially opened their interactive online exhibition, Art of Science, which features incredible biomedical images from WEHI researchers.
PMRI: Digital Education Platform Project - Pain Management
PMRI is developing digital pain education to support the emerging, current and future health workforce and improve the lives of patients with chronic pain.
VCCRI: 'Heart in a Box'
An Australian method of preserving donated hearts has boosted the number of successful transplants across the world, with new research demonstrating similar survival rates to traditional transplants.
WEHI: Say Hi to the life-saving impact of medical research discoveries
HM1 beneficiary Walter and Eliza Hall Institute recently released a video dedicated to the life-saving impact of long-term medical research discoveries.
Cerebral Palsy Alliance: Changing the GAME
A research team at Cerebral Palsy Alliance is working to develop a world-first, early-intervention therapy approach for infants with cerebral palsy called ‘GAME’ (Goals, Activity, Motor Enrichment).
The Florey: New target in MND drug discovery
The Florey investigates how a previously underappreciated cell type potentially contributes to the progressive loss of motor neurons in Motor Neurone Disease (MND).
Remarkable Demo Day 2022: Disability-tech accelerator
Remarkable, Australia’s first disability-tech accelerator made possible by Cerebral Palsy Alliance, has released a video sharing the innovative products developed by the 2022 cohort.
Black Dog: Space 22
Black Dog Institute’s art-based researcher Professor Katherine Boydell is starring in an ABC documentary series, Space 22, hosted by Natalie Bassingthwaighte. The series follows those with lived experience of mental ill health.
WEHI: New findings could lead to cancer therapy without harmful side-effects
Researchers at WEHI have developed a way to potentially reduce the toxic side-effects of a type of immunotherapy, in findings that could overcome the pioneering treatment’s biggest limitation.
Victor Chang: Innovation Centre
COVID-19 may have stopped tours of Victor Chang's Innovation Centre but it certainly hasn’t slowed their scientists from making new discoveries as shown in this video with Sky News Australia.
More Podcasts
Understanding the 4 pillar framework underpinning a high conviction strategy
Listen to episode one with Chief Investment Officer Charlie Lanchester and TDM Growth Partners Investment Team Members Ed Cowan and Fraser Christie. They share their unique investment philosophies and delve into two high conviction stocks recommended for the HM1 portfolio.


